НовостиBenzingaCitigroup Maintains Buy on Caris Life Sciences, Raises Price Target to $36 Citigroup Maintains Buy on Caris Life Sciences, Raises Price Target to $36 Benzinga 2026.11.06 21:25 (GMT+0) Открыть на Benzinga Другие новости